WINTON GROUP Ltd lessened its holdings in Grand Canyon Education Inc (NASDAQ:LOPE) by 27.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,714 shares of the company’s stock after selling 6,623 shares during the period. WINTON GROUP Ltd’s holdings in Grand Canyon Education were worth $1,977,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Conestoga Capital Advisors LLC raised its position in shares of Grand Canyon Education by 4.6% in the second quarter. Conestoga Capital Advisors LLC now owns 667,172 shares of the company’s stock worth $74,463,000 after buying an additional 29,197 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Grand Canyon Education by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 550,261 shares of the company’s stock worth $61,415,000 after buying an additional 25,931 shares in the last quarter. Millennium Management LLC raised its position in shares of Grand Canyon Education by 150.2% in the second quarter. Millennium Management LLC now owns 471,913 shares of the company’s stock worth $52,670,000 after buying an additional 283,325 shares in the last quarter. Lord Abbett & CO. LLC raised its position in shares of Grand Canyon Education by 9.3% in the first quarter. Lord Abbett & CO. LLC now owns 467,085 shares of the company’s stock worth $49,007,000 after buying an additional 39,860 shares in the last quarter. Finally, Waddell & Reed Financial Inc. purchased a new stake in shares of Grand Canyon Education in the second quarter worth $51,907,000. Institutional investors own 94.24% of the company’s stock.
Best Heal Care Stocks To Watch For 2019: TiVo Inc.(TIVO)
Advisors’ Opinion:
- [By Rich Duprey]
TiVo (NASDAQ:TIVO) can’t get out of the digital TV recorder business fast enough. But with Amazon.com (NASDAQ:AMZN) now reportedly developing its own DVR product to record live TV programming, TiVo’s chances of finding an interested buyer have probably decreased dramatically.
- [By Anders Bylund]
Shares of TiVo (NASDAQ:TIVO) gained 18.3% in January of 2019, according to data from S&P Global Market Intelligence. The month started with a favorable decision from the U.S. Patent and Trademark Office, which sent the media-management expert’s stock more than 5% higher in a single day. From there, TiVo investors simply followed suit with a generally rising stock market.
- [By Joseph Griffin]
TiVo Corp (NASDAQ:TIVO) – Equities research analysts at B. Riley reduced their Q1 2019 earnings per share (EPS) estimates for TiVo in a report issued on Wednesday, February 27th. B. Riley analyst E. Wold now forecasts that the technology company will post earnings per share of $0.10 for the quarter, down from their previous forecast of $0.16. B. Riley also issued estimates for TiVo’s Q2 2019 earnings at $0.10 EPS, Q3 2019 earnings at $0.10 EPS, Q4 2019 earnings at $0.11 EPS, FY2019 earnings at $0.41 EPS, Q1 2020 earnings at $0.12 EPS, Q2 2020 earnings at $0.12 EPS, Q3 2020 earnings at $0.13 EPS, Q4 2020 earnings at $0.14 EPS and FY2020 earnings at $0.51 EPS.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on TiVo (TIVO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By ]
Engaged Capital maintained large positions in Rent-A-Center (RCII) , TiVo (TIVO) , Hain Celestial (HAIN) , SunOpta and Jamba Inc. (JMBA) , all companies that have either previously been targeted by Welling or currently are in his cross-hairs.
Best Heal Care Stocks To Watch For 2019: SINOPEC Shangai Petrochemical Company Ltd.(SHI)
Advisors’ Opinion:
- [By Shane Hupp]
SIG (LON:SHI) had its target price dropped by stock analysts at Peel Hunt from GBX 185 ($2.41) to GBX 180 ($2.34) in a research report issued to clients and investors on Friday. The brokerage currently has a “buy” rating on the stock. Peel Hunt’s target price would suggest a potential upside of 47.06% from the stock’s current price.
- [By Joseph Griffin]
Press coverage about Shanghai Petrochemical (NYSE:SHI) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Shanghai Petrochemical earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave media headlines about the oil and gas company an impact score of 44.8127005121821 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
- [By Stephan Byrd]
Shanghai Petrochemical (NYSE: SHI) and Eastman Chemical (NYSE:EMN) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.
Best Heal Care Stocks To Watch For 2019: Merit Medical Systems Inc.(MMSI)
Advisors’ Opinion:
- [By Shane Hupp]
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribing]
Merit Medical Systems (NASDAQ:MMSI) Q2 2018 Earnings Conference CallJul. 23, 2018 5:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $52.00.
- [By Max Byerly]
Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.97-2.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.97. The company issued revenue guidance of $1.011-1.03 billion, compared to the consensus revenue estimate of $1.01 billion.
Best Heal Care Stocks To Watch For 2019: Ironwood Pharmaceuticals Inc.(IRWD)
Advisors’ Opinion:
- [By Logan Wallace]
Get a free copy of the Zacks research report on Ironwood Pharmaceuticals (IRWD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Todd Campbell]
After reporting fourth-quarter financial results that were better than expected on both the top and bottom line and updating investors on its plans to split into two companies, Ironwood Pharmaceuticals (NASDAQ:IRWD) surged 11.7% higher today.
- [By Motley Fool Transcribers]
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)Q4 2018 Earnings Conference CallFeb. 13, 2019, 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator